Molecular Masking of Synthetic Immunomodulator Evokes Antitumor Immunity With Reduced Immune Tolerance and Systemic Toxicity by Temporal Activity Recovery and Sustained Stimulation

Molecular Masking of Synthetic Immunomodulator Evokes Antitumor Immunity With Reduced Immune Tolerance and Systemic Toxicity by Temporal Activity Recovery and Sustained Stimulation

© 2023 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 9 vom: 29. März, Seite e2309039
1. Verfasser: Shin, Hong Sik (VerfasserIn)
Weitere Verfasser: Kim, Sohyun, Jin, Seung Mo, Yoo, Yeon Jeong, Heo, Jang Hun, Lim, Yong Taik
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article cancer immunotherapy immune checkpoint inhibitors immune stimulation immune tolerance immunosuppression toll-like receptor agonist Toll-Like Receptor 7 Immunologic Factors Adjuvants, Immunologic
Online verfügbar Volltext